New Exploratory Alzheimer's Drug ANAVEX 2-73 Changes in Electrophysiological Markers in Alzheimer's
- ANAVEX® Life Sciences Corp.
- Nov 11, 2015
- 1 min read
First Patient Data from an ongoing Phase 2a Study in mild-to-moderate Alzheimer's patients.
Alzheimer’s Association International Conference® (AAIC) 2015, Washington, DC
Steve Macfarlane, Marco Cecchi, Dennis Moore, Anastasios Zografidis and Christopher Missling
